Round Hill Asset Management maintained its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 19,715 shares of the medical equipment provider’s stock at the end of the 2nd quarter. Zimmer Biomet Holdings accounts for 1.5% of Round Hill Asset Management’s portfolio, making the stock its 18th largest position. Round Hill Asset Management’s holdings in Zimmer Biomet Holdings were worth $2,531,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently made changes to their positions in ZBH. Flinton Capital Management LLC boosted its position in Zimmer Biomet Holdings by 12.4% during the first quarter. Flinton Capital Management LLC now owns 9,520 shares of the medical equipment provider’s stock worth $1,162,000 after purchasing an additional 1,054 shares during the period. FTB Advisors Inc. boosted its position in Zimmer Biomet Holdings by 521.3% during the first quarter. FTB Advisors Inc. now owns 2,572 shares of the medical equipment provider’s stock worth $314,000 after purchasing an additional 2,158 shares during the period. DekaBank Deutsche Girozentrale boosted its position in Zimmer Biomet Holdings by 120.3% during the first quarter. DekaBank Deutsche Girozentrale now owns 134,569 shares of the medical equipment provider’s stock worth $16,414,000 after purchasing an additional 73,489 shares during the period. TIAA CREF Trust Co. FSB MO boosted its position in Zimmer Biomet Holdings by 5.5% during the first quarter. TIAA CREF Trust Co. FSB MO now owns 76,175 shares of the medical equipment provider’s stock worth $9,302,000 after purchasing an additional 4,003 shares during the period. Finally, Boston Partners boosted its position in Zimmer Biomet Holdings by 10.7% during the first quarter. Boston Partners now owns 1,236,616 shares of the medical equipment provider’s stock worth $151,004,000 after purchasing an additional 119,955 shares during the period. 85.48% of the stock is owned by hedge funds and other institutional investors.

In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction on Monday, July 31st. The stock was sold at an average price of $121.74, for a total value of $2,067,875.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.07% of the stock is owned by insiders.

A number of equities research analysts have issued reports on the company. Morgan Stanley upped their target price on Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, July 17th. Stifel Nicolaus reaffirmed a “hold” rating and set a $125.00 target price on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Piper Jaffray Companies reissued a “buy” rating and issued a $141.00 price objective on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Bank of America Corporation reissued a “buy” rating and issued a $158.00 price objective on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Finally, Wells Fargo & Company reissued a “market weight” rating on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $136.75.

WARNING: This piece was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/09/16/round-hill-asset-management-continues-to-hold-position-in-zimmer-biomet-holdings-inc-zbh.html.

Zimmer Biomet Holdings, Inc. (NYSE ZBH) traded down 0.45% on Friday, reaching $115.47. The company’s stock had a trading volume of 1,626,722 shares. The company has a market cap of $23.35 billion, a P/E ratio of 32.89 and a beta of 1.21. The company has a 50-day moving average price of $114.88 and a 200 day moving average price of $120.74. Zimmer Biomet Holdings, Inc. has a 12 month low of $95.63 and a 12 month high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by ($0.02). The company had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.95 billion. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. Zimmer Biomet Holdings’s revenue was up 1.1% on a year-over-year basis. During the same period in the prior year, the firm earned $2.02 earnings per share. On average, equities research analysts anticipate that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be issued a $0.24 dividend. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 annualized dividend and a yield of 0.83%. Zimmer Biomet Holdings’s dividend payout ratio is presently 27.59%.

Zimmer Biomet Holdings Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.